Your shopping cart is currently empty

BM-131246 is an orally available and antidiabetic active thiazolidinedione derivative for the study of diabetes.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $700 | - | In Stock | |
| 5 mg | $1,800 | - | In Stock |
| Description | BM-131246 is an orally available and antidiabetic active thiazolidinedione derivative for the study of diabetes. |
| In vivo | After repeated oral doses, BM-131246 attains approximately proportional increases in plasma levels in ob/ob mice. The terminal half-life for BM-131246 is about 4 h[1], and it is quickly absorbed into the bloodstream. |
| Molecular Weight | 408.47 |
| Formula | C22H20N2O4S |
| Cas No. | 103787-97-9 |
| Smiles | O=C1SC(C(=O)N1)CC2=CC=C(OCCC=3N=C(OC3C)C=4C=CC=CC4)C=C2 |
| Relative Density. | 1.299 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.